JAK2-IN-7
JAK2-IN-7 is a selective JAK2 inhibitor with IC50s of 3, 11.7, and 41 nM for JAK2, SET-2, and Ba/F3V617F cells, respectively. JAK2-IN-7 possesses >14-fold selectivity over JAK1, JAK3, FLT3. JAK2-IN-7 stimulates cell cycle arrest in the G0/G1 phase and induces tumor cellapoptosis. Antitumor activities[1].
Product Specifications
CAS Number
2593402-36-7
UNSPSC
12352005
Target
Apoptosis; FLT3; JAK
Type
Reference compound
Related Pathways
Apoptosis; Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/jak2-in-7.html
Purity
99.15
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
CC1=C(N=C(N=C1)NC2=CC=C3CN(CCC3=C2)C(/C=C/CN(C)C)=O)C4=CN(N=C4)C(C)C
Molecular Formula
C26H33N7O
Molecular Weight
459.59
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
JAK1; JAK2; JAK3; Tyk2
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
GATA-3 (Breast and Urothelial Marker) (GATA3/2445), CF594 conjugate, 0.1mg/mL
Replication Protein A2 (RPA2) (RPA2/2106), CF640R conjugate, 0.1mg/mL
Phosphatidic acid phosphatase type 2B (PLPP3) (NM_003713) Human Recombinant Protein
